CX717
| Clinical data | |
|---|---|
| Routes of administration | By mouth, IV |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C11H11N3O3 |
| Molar mass | 233.227 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
CX717 is an ampakine compound created by Christopher Marrs and Gary Rogers in 1996 at Cortex Pharmaceuticals. It affects the neurotransmitter glutamate, with trials showing the drug improves cognitive functioning and memory.
Category:
- Drugs not assigned an ATC code